People · Operator
Named in public records as an officer, director or promoter · active 2020–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InSitu Biologics, Inc | — | Biotechnology | Series A | $13.9M | $10.7M | 2020 |
Andy LaFrence at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andy LaFrence on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BUZZ BENSON | 1 | 8 |
| Robert Wilson | 1 | 7 |
| Kevin Barrett | 1 | 5 |
| James Knapp | 1 | 3 |
| Kevin Bassett | 1 | 2 |
| Ivan Shaw | 1 | 1 |
| Mark Ereth | 1 | 1 |
| Kay Warnott | 1 | 1 |
| Jim Segermark | 1 | 1 |
| Bill Taylor | 1 | 1 |
| Greg Van Guilder | 1 | 1 |
| Daniel Halpern | 1 | 1 |
| Sandi Klemann | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.